...
首页> 外文期刊>Clinical Pediatrics >Physician communication regarding cost when prescribing asthma medication to children.
【24h】

Physician communication regarding cost when prescribing asthma medication to children.

机译:在为儿童开处方哮喘药物时,医师会就费用进行沟通。

获取原文
获取原文并翻译 | 示例

摘要

Children with asthma require multiple medications, and cost may be a barrier to care. The purpose of this study was to determine how often physicians ask about cost when prescribing new asthma medication and to identify factors influencing queries. We surveyed pediatricians and family physicians and asked whether they asked about cost when prescribing new asthma medication and if cost was a barrier to prescribing. One third of physicians (35%) reported that concern for cost to the family was a barrier to prescribing. Half reported not asking their patients about drug costs. Pediatricians were less likely to ask about cost (odds ratio [OR] = 0.43; 95% confidence interval [CI] = 0.20-0.92) when compared with family physicians. For every 10% increase in the number of privately insured patients, a physician was less likely to ask about cost (OR = 0.83; 95% CI = 0.74-0.94). Communication about medication costs should be included in childhood asthma management.
机译:哮喘患儿需要多种药物治疗,费用可能会成为护理的障碍。这项研究的目的是确定医生在开新的哮喘药物时询问费用的频率,并确定影响查询的因素。我们对儿科医生和家庭医生进行了调查,询问他们在开新的哮喘药物时是否询问费用以及费用是否对开处方构成障碍。三分之一的医生(35%)报告说,对家庭费用的担忧是开处方的障碍。一半的人报告没有询问患者有关药物的费用。与家庭医生相比,儿科医生不太可能询问费用(赔率[OR] = 0.43; 95%置信区间[CI] = 0.20-0.92)。私人保险患者人数每增加10%,医生询问费用的可能性就较小(OR = 0.83; 95%CI = 0.74-0.94)。儿童哮喘治疗中应包括有关用药费用的交流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号